THYROID STORM: FROM ENDOCRINE CRISIS TO CARDIOVASCULAR COLLAPSE — PATHOPHYSIOLOGY, DIAGNOSIS AND CONTEMPORARY MANAGEMENT
DOI:
https://doi.org/10.31435/ijitss.3(51).2026.6569Keywords:
Thyrotoxicosis, Thyroid Storm, Organ Failure, Cardiac Arrest, TachyarrhythmiaAbstract
Thyroid storm is a rare but life-threatening endocrine emergency characterized by thyrotoxicosis accompanied by systemic decompensation and end-organ dysfunction. Despite advances in diagnosis and treatment, it remains associated with substantial mortality, cardiovascular failure and multiorgan dysfunction representing major causes of death. This narrative review aims to summarize current knowledge regarding the pathophysiology, clinical presentation, diagnostic approaches, cardiovascular complications, and contemporary treatment strategies for thyroid storm, with particular emphasis on the management of severe cardiovascular manifestations. A narrative literature review was conducted using PubMed and Google Scholar. Recent peer-reviewed studies, systematic reviews, case series, clinical guidelines, and international consensus recommendations were analyzed to provide an up-to-date overview of thyroid storm management. Thyroid storm requires rapid recognition based on clinical manifestations of systemic decompensation in the setting of biochemical thyrotoxicosis. Cardiovascular complications, including tachyarrhythmias, atrial fibrillation, acute heart failure, thyrotoxic cardiomyopathy, myocardial injury, cardiogenic shock, and cardiac arrest, are among the most clinically significant complications. Treatment requires a multimodal approach - antithyroid drugs, iodine, glucocorticoids, β-blockers, and supportive intensive care. Propranolol remains an important therapeutic option; however, β-blockade must be individualized in patients with impaired cardiac function or hemodynamic instability. Alternative and rescue therapies, including lithium, cholestyramine, therapeutic plasma exchange, and thyroidectomy, may be considered in refractory cases. Successful management of thyroid storm requires early diagnosis, prompt treatment, continuous cardiovascular monitoring, and an individualized multidisciplinary approach. Further studies are needed to establish optimal treatment strategies, particularly for patients with cardiovascular complications and those who fail or cannot tolerate conventional therapy.
References
De Almeida, R., McCalmon, S., & Cabandugama, P. K. (2022). Clinical review and update on the management of thyroid storm. Missouri Medicine, 119(4), 366–371.
Elendu, C., Amaechi, D. C., Amaechi, E. C., Chima-Ogbuiyi, N. L., Afuh, R. N., Arrey Agbor, D. B., Abdi, M. A., Nwachukwu, N. O., Oderinde, O. O., Elendu, T. C., Elendu, I. D., Akintunde, A. A., Onyekweli, S. O., & Omoruyi, G. O. (2024). Diagnostic criteria and scoring systems for thyroid storm: An evaluation of their utility – comparative review. Medicine, 103(13), e37396. https://doi.org/10.1097/MD.0000000000037396
Kopp, P. A., Giordani, I., Feldt-Rasmussen, U., & Forget-Renaud, A. (2026). Approach to the patient with thyroid storm. The Journal of Clinical Endocrinology & Metabolism, 111(5), 1484–1494. https://doi.org/10.1210/clinem/dgag054
Niedzialkowska, E., Steafo, L., Alsabti, S., & Kim, A. (2024). Pembrolizumab-induced thyroid storm. Proceedings (Baylor University. Medical Center), 38(2), 199–201. https://doi.org/10.1080/08998280.2024.2413320
António Santos, C., Vassalo, A. F., Rocha, J., Alves Cardoso, A., & Trigueiros, F. (2025). Thyroid storm: A case report. Cureus, 17(5), e84694. https://doi.org/10.7759/cureus.84694
Osorio-Toro, L. M., Ordoñez-Guzman, Y. A., Quintana-Ospina, J. H., Vergara-Portocarrero, M. L., Lizarazo-Herrera, E. A., Daza-Arana, J. E., Rodríguez-Scarpetta, M. A., Restrepo-Erazo, K., & García Ramos, A. F. (2025). Plasmapheresis for the treatment of thyroid storm. Endocrinology, Diabetes & Metabolism Case Reports, 2025(4), e250010. https://doi.org/10.1530/EDM-25-0010
Lee, S. Y., Modzelewski, K. L., Law, A. C., Walkey, A. J., Pearce, E. N., & Bosch, N. A. (2023). Comparison of propylthiouracil vs methimazole for thyroid storm in critically ill patients. JAMA Network Open, 6(4), e238655. https://doi.org/10.1001/jamanetworkopen.2023.8655
Barnett, M. J. L., Casipit, C., Sathi, S. R. T., & Rodriguez, A. D. C. R. (2024). Rectal thionamide administration in the setting of thyroid storm: A case report and review of the literature. Endocrinology, Diabetes & Metabolism Case Reports, 2024(3), 24-0067. https://doi.org/10.1530/EDM-24-0067
Matsuo, Y., Miyawaki, A., Watanabe, H., Matsui, H., Fushimi, K., & Yasunaga, H. (2025). Potassium iodide use and patient outcomes for thyroid storm: An observational study. The Journal of Clinical Endocrinology & Metabolism, 110(2), e310–e320. https://doi.org/10.1210/clinem/dgae187
Sharma, P. P. (2022). Use of lithium in hyperthyroidism secondary to Graves' disease: A case report. American Journal of Case Reports, 23, e935789. https://doi.org/10.12659/AJCR.935789
Lassoued, N., Alaya, W., Rebai, S., Arfa, S., Zantour, B., & Habib Sfar, M. (2023). Acute adrenal crisis precipitated by thyroid storm in a patient with undiagnosed autoimmune polyglandular syndrome type 2. Endocrinology, Diabetes & Metabolism Case Reports, 2023(2), 21-0152. https://doi.org/10.1530/EDM-21-0152
Qwaider, M., Hassouna, N., Safi, M., Elhady, M., Pragani, M., Alqadi, M., Qafisheh, Q., Jodeh, W., & Safi, F. (2026). Use of plasmapheresis and cholestyramine in the management of thyroid storm in the setting of cardiogenic shock and elevated liver enzymes: A case report and review of literature. AACE Endocrinology and Diabetes, 13(4), 560–565. https://doi.org/10.1016/j.aed.2026.03.009
Tian, K., Liang, T., Yew, J., & Chng, C. L. (2024). Management of perioperative thyrotoxicosis – what to do when standard therapy is contraindicated or fails? Frontiers in Endocrinology, 15, 1498014. https://doi.org/10.3389/fendo.2024.1498014
Obi, M. F., Namireddy, V., Garg, Y., & Sharma, M. (2023). Benefit and preference of propranolol over metoprolol in thyrotoxicosis-induced atrial fibrillation: A case report and review of literature. Cureus, 15(1), e34474. https://doi.org/10.7759/cureus.34474
Bokhari, S. F. H., Sattar, H., Abid, S., Vohra, R. R., & Sajid, S. (2022). Cardiovascular collapse secondary to beta-blocker administration in a setting of coexisting thyroid storm and atrial fibrillation: A case report. Cureus, 14(9), e29321. https://doi.org/10.7759/cureus.29321
Afifi, S., Suryadevara, V., Habab, Y., Hutcheson, A., Panjiyar, B. K., Davydov, G. G., Nashat, H., Ghali, S., & Khan, S. (2023). Comparing the incidence of propranolol and esmolol-related cardiac arrest in patients with thyroid storm: A systematic literature review. Cureus, 15(9), e44655. https://doi.org/10.7759/cureus.44655
Rami, I., Zerrouki, D., Assarrar, I., Rouf, S., & Latrech, H. (2024). Plasmapheresis in thyrotoxicosis: A single-center case series. Journal of Medical Case Reports, 18(1), 193. https://doi.org/10.1186/s13256-024-04480-9
de Mul, N., Damstra, J., Nieveen van Dijkum, E. J. M., Fischli, S., Kalkman, C. J., Schellekens, W. M., & Immink, R. V. (2021). Risk of perioperative thyroid storm in hyperthyroid patients: A systematic review. British Journal of Anaesthesia, 127(6), 879–889. https://doi.org/10.1016/j.bja.2021.06.043
Elmenyar, E., Aoun, S., Al Saadi, Z., Barkumi, A., Cander, B., Al-Thani, H., & El-Menyar, A. (2023). Data analysis and systematic scoping review on the pathogenesis and modalities of treatment of thyroid storm complicated with myocardial involvement and shock. Diagnostics, 13(19), 3028. https://doi.org/10.3390/diagnostics13193028
El-Menyar, A., Khan, N. A., Elmenyar, E., Cander, B., Szarpak, L., Krishnan, S. V., Galwnkar, S., & Al-Thani, H. (2025). Thyroid storm-induced cardiovascular complications and modalities of therapy: Up-to-date review. World Journal of Critical Care Medicine, 14(4), 109565. https://doi.org/10.5492/wjccm.v14.i4.109565
Taylor, P., Okosieme, O., Effraimidis, G., Gibb, F., Parekh, D., Moran, C., Kopp, P., & Boelaert, K. (2026). Management of thyroid emergencies: Joint consensus statement on management of thyroid storm. European Thyroid Journal, 15(4), ETJ260043. https://doi.org/10.1530/ETJ-26-0043
Hamed, M., Palumbo, S., & Mendha, T. (2022). Severe cardiovascular effects of prolonged untreated hyperthyroidism manifesting as thyroid storm. Cureus, 14(6), e26289. https://doi.org/10.7759/cureus.26289
Mansoor, T., Kaur, J., Randhawa, M., Rai, A., Yu, D., Khan, F. I., & Koshy, S. (2024). Iatrogenic cardiac arrest during thyroid storm. European Journal of Case Reports in Internal Medicine, 11(12), 004958. https://doi.org/10.12890/2024_004958
Zayour, M., Yasmin, F. A., Baydoun, A., Tawk, M., Sleiman, D., Shatila, W., & Chamoun, C. (2023). Cardiac arrest as first presentation of thyroid storm. Cureus, 15(4), e37057. https://doi.org/10.7759/cureus.37057
Eatz, T. A., Rios, P., Penaherrera Oviedo, C. A., & Lagari, V. (2023). Thyroid storm triggered by thyroid nodule fine needle aspiration biopsy: A case report. AME Case Reports, 8, 15. https://doi.org/10.21037/acr-23-63
Herzallah, Z. N., Gupta, S., Abdulhamid, M. D., & Muhammed Noori, O. Q. (2023). Esmolol is not the solution: Thyroid storm with atrial fibrillation. Cureus, 15(2), e35201. https://doi.org/10.7759/cureus.35201
Seo, Y.-J., Chervu, N., Benharash, P., & Wu, J. X. (2024). National trends and outcomes in the operative management of thyroid storm. The American Surgeon, 90(10), 2424–2430. https://doi.org/10.1177/00031348241248704
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Małgorzata Grzybowska, Piotr Wilczkowski, Aleksandra Palka, Natalia Krzysztofek, Wojciech Kopyciński, Katarzyna Boszczyk, Norbert Krawczyk, Monika Kamela, Adrianna Baran, Olaf Krawczyk
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
